Cargando…

Hypopituitarism after subarachnoid haemorrhage, do we know enough?

BACKGROUND: Fatigue, slowness, apathy and decrease in level of activity are common long-term complaints after a subarachnoid haemorrhage (SAH). They resemble the symptoms frequently found in patients with endocrine dysfunction. Pituitary dysfunction may be the result of SAH or its complications. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Khajeh, Ladbon, Blijdorp, Karin, Neggers, Sebastian JCMM, Ribbers, Gerard M, Dippel, Diederik WJ, van Kooten, Fop
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207357/
https://www.ncbi.nlm.nih.gov/pubmed/25312299
http://dx.doi.org/10.1186/s12883-014-0205-0
_version_ 1782340953969786880
author Khajeh, Ladbon
Blijdorp, Karin
Neggers, Sebastian JCMM
Ribbers, Gerard M
Dippel, Diederik WJ
van Kooten, Fop
author_facet Khajeh, Ladbon
Blijdorp, Karin
Neggers, Sebastian JCMM
Ribbers, Gerard M
Dippel, Diederik WJ
van Kooten, Fop
author_sort Khajeh, Ladbon
collection PubMed
description BACKGROUND: Fatigue, slowness, apathy and decrease in level of activity are common long-term complaints after a subarachnoid haemorrhage (SAH). They resemble the symptoms frequently found in patients with endocrine dysfunction. Pituitary dysfunction may be the result of SAH or its complications. We therefore hypothesized that it may explain some of the long-term complaints after SAH. We reviewed the literature to clarify the occurrence, pattern and severity of endocrine abnormalities and we attempted to identify risk factors for hypopituitarism after SAH. We also assessed the effect of hypopituitarism on long-term functional recovery after SAH. METHODS: In a MEDLINE search for studies published between 1995 and 2014, we used the term subarachnoid haemorrhage in combination with pituitary, hypopituitarism, growth hormone, gonadotropin, testosterone, cortisol function, thyroid function and diabetes insipidus. We selected all case-series and cohort studies reporting endocrine function at least 3 months after SAH and studied their reported prevalence, pathogenesis, risk factors, clinical course and outcome. RESULTS: We identified 16 studies describing pituitary function in the long term after SAH. The reported prevalence of endocrine dysfunction varied from 0 to 55% and the affected pituitary axes differed between studies. Due to methodological issues no inferences on risk factors, course and outcome could be made. CONCLUSIONS: Neuroendocrine dysfunction may be an important and modifiable determinant of poor functional outcome after SAH. There is an urgent need for well-designed prospective studies to more precisely assess its incidence, clinical course and effect on mood, behaviour and quality of life. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12883-014-0205-0) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4207357
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42073572014-10-28 Hypopituitarism after subarachnoid haemorrhage, do we know enough? Khajeh, Ladbon Blijdorp, Karin Neggers, Sebastian JCMM Ribbers, Gerard M Dippel, Diederik WJ van Kooten, Fop BMC Neurol Research Article BACKGROUND: Fatigue, slowness, apathy and decrease in level of activity are common long-term complaints after a subarachnoid haemorrhage (SAH). They resemble the symptoms frequently found in patients with endocrine dysfunction. Pituitary dysfunction may be the result of SAH or its complications. We therefore hypothesized that it may explain some of the long-term complaints after SAH. We reviewed the literature to clarify the occurrence, pattern and severity of endocrine abnormalities and we attempted to identify risk factors for hypopituitarism after SAH. We also assessed the effect of hypopituitarism on long-term functional recovery after SAH. METHODS: In a MEDLINE search for studies published between 1995 and 2014, we used the term subarachnoid haemorrhage in combination with pituitary, hypopituitarism, growth hormone, gonadotropin, testosterone, cortisol function, thyroid function and diabetes insipidus. We selected all case-series and cohort studies reporting endocrine function at least 3 months after SAH and studied their reported prevalence, pathogenesis, risk factors, clinical course and outcome. RESULTS: We identified 16 studies describing pituitary function in the long term after SAH. The reported prevalence of endocrine dysfunction varied from 0 to 55% and the affected pituitary axes differed between studies. Due to methodological issues no inferences on risk factors, course and outcome could be made. CONCLUSIONS: Neuroendocrine dysfunction may be an important and modifiable determinant of poor functional outcome after SAH. There is an urgent need for well-designed prospective studies to more precisely assess its incidence, clinical course and effect on mood, behaviour and quality of life. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12883-014-0205-0) contains supplementary material, which is available to authorized users. BioMed Central 2014-10-14 /pmc/articles/PMC4207357/ /pubmed/25312299 http://dx.doi.org/10.1186/s12883-014-0205-0 Text en © Khajeh et al.; licensee BioMed Central Ltd. 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
spellingShingle Research Article
Khajeh, Ladbon
Blijdorp, Karin
Neggers, Sebastian JCMM
Ribbers, Gerard M
Dippel, Diederik WJ
van Kooten, Fop
Hypopituitarism after subarachnoid haemorrhage, do we know enough?
title Hypopituitarism after subarachnoid haemorrhage, do we know enough?
title_full Hypopituitarism after subarachnoid haemorrhage, do we know enough?
title_fullStr Hypopituitarism after subarachnoid haemorrhage, do we know enough?
title_full_unstemmed Hypopituitarism after subarachnoid haemorrhage, do we know enough?
title_short Hypopituitarism after subarachnoid haemorrhage, do we know enough?
title_sort hypopituitarism after subarachnoid haemorrhage, do we know enough?
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207357/
https://www.ncbi.nlm.nih.gov/pubmed/25312299
http://dx.doi.org/10.1186/s12883-014-0205-0
work_keys_str_mv AT khajehladbon hypopituitarismaftersubarachnoidhaemorrhagedoweknowenough
AT blijdorpkarin hypopituitarismaftersubarachnoidhaemorrhagedoweknowenough
AT neggerssebastianjcmm hypopituitarismaftersubarachnoidhaemorrhagedoweknowenough
AT ribbersgerardm hypopituitarismaftersubarachnoidhaemorrhagedoweknowenough
AT dippeldiederikwj hypopituitarismaftersubarachnoidhaemorrhagedoweknowenough
AT vankootenfop hypopituitarismaftersubarachnoidhaemorrhagedoweknowenough